MPLT MapLight Therapeutics, Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$25.52
Price · May 20, 2026
Fundamentals as of May 14, 2026

MPLT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$25.52
Market Cap
$773M
P/E (TTM)
-0.9
EPS (TTM)
$-18.56
Revenue (TTM)
Div Yield
ROE
-151.1%
Debt/Equity
52W Range
$12 – $33

MPLT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS $-18.56
2-point trend, +82.4%
2024-12-31 2025-12-31
Free Cash Flow $-139M
2025-12-31 2025-12-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
MPLT
Peer Median
P/E (TTM)
-0.9
P/B
1.7
5.6
Price / FCF
-5.6

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
MPLT
Peer Median
ROA
-52.3%
-51.4%
ROE
-151.1%
-78.8%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
MPLT
Peer Median
Current Ratio
20.0
9.0
Quick Ratio
18.8

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
MPLT
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
MPLT
Peer Median
EPS (Diluted)
2-point trend, +82.4%
$-18.56

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
MPLT
Peer Median

MPLT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 13 analysts
  • Strong Buy 5 38.5%
  • Buy 7 53.8%
  • Hold 1 7.7%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

8 analysts · 2026-05-17
Median target $34.50 +35.2%
Mean target $36.00 +41.1%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-12.4%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-1.34 $-1.12 -0.22%
Dec. 31, 2025 $-2.47 $-0.98 -1.5%
Sept. 30, 2025 $-37.18 $-1.76 -35.4%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
MPLT $773M -0.9 -151.1%
AVBP $854M -4.7 -59.7%
OLMA $2.03B -13.4 -39.4%
ZBIO $1.98B -4.3 100.0% -3777.4% -156.8%
JBIO $761M -4.8 -47.7%
PURR
CDNA $959M -47.1 13.8% -5.6% -6.8%
AKTS
CRVS $575M -14.5 -21.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 12
Annual Income Statement data for MPLT
Metric Trend 20252024
R&D Expense 2-point trend, +101.9% $138M $69M
SG&A Expense 2-point trend, +113.1% $31M $14M
Operating Expenses 2-point trend, +103.8% $169M $83M
Operating Income 2-point trend, -103.8% $-169M $-83M
Interest Income 2-point trend, +22.5% $6M $5M
Other Non-op 2-point trend, +30.6% $2M $2M
Net Income 2-point trend, -107.7% $-161M $-78M
EPS (Basic) 2-point trend, +82.4% $-18.56 $-105.38
EPS (Diluted) 2-point trend, +82.4% $-18.56 $-105.38
Shares (Basic) 2-point trend, +1079.2% 8,680,741 736,178
Shares (Diluted) 2-point trend, +1079.2% 8,680,741 736,178
EBITDA $-169M ·
Balance Sheet 20
Annual Balance Sheet data for MPLT
Metric Trend 20252024
Cash & Equivalents 2-point trend, +22.2% $47M $38M
Short-term Investments 2-point trend, +266.3% $258M $71M
Prepaid Expense 2-point trend, +237.0% $20M $6M
Current Assets 2-point trend, +183.3% $325M $115M
PP&E (Net) 2-point trend, -9.3% $1M $1M
PP&E (Gross) 2-point trend, +13.5% $4M $3M
Accum. Depreciation 2-point trend, +26.8% $3M $2M
Other Non-current Assets 2-point trend, -98.1% $59.0K $3M
Total Assets 2-point trend, +250.2% $480M $137M
Accounts Payable 2-point trend, +72.0% $3M $2M
Accrued Liabilities 2-point trend, +20.6% $12M $10M
Current Liabilities 2-point trend, +1.9% $16M $16M
Capital Leases 2-point trend, -15.3% $5M $6M
Total Liabilities 2-point trend, -2.7% $21M $22M
Common Stock 2-point trend, +5000.00 $5.0K $0
Retained Earnings 2-point trend, -80.8% $-361M $-199M
AOCI 2-point trend, -239.9% $-228.0K $163.0K
Stockholders' Equity 2-point trend, +336.7% $458M $-194M
Liabilities + Equity 2-point trend, +250.2% $480M $137M
Shares Outstanding 2-point trend, +5682.9% 44,024,088 761,276
Cash Flow 6
Annual Cash Flow data for MPLT
Metric Trend 20252024
Stock-based Comp 2-point trend, +3233.9% $36M $1M
Operating Cash Flow 2-point trend, -75.3% $-138M $-79M
CapEx 2-point trend, -38.6% $473.0K $770.0K
Investing Cash Flow 2-point trend, -300.1% $-323M $-81M
Financing Cash Flow 2-point trend, +298.0% $470M $118M
Free Cash Flow $-139M ·
Profitability 2
Annual Profitability data for MPLT
Metric Trend 20252024
ROA -52.3% ·
ROE -151.1% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for MPLT
Metric Trend 20252024
Current Ratio 20.0 ·
Quick Ratio 18.8 ·
Per Share 4
Annual Per Share data for MPLT
Metric Trend 20252024
Book Value / Share $10.41 ·
Cash Flow / Share $-15.91 ·
Cash / Share $1.06 ·
EPS (TTM) $-18.56 ·
Valuation (TTM) 8
Annual Valuation (TTM) data for MPLT
Metric Trend 20252024
Net Income TTM $-161M ·
Market Cap $773M ·
P/E -0.9 ·
P/B 1.7 ·
P / Tangible Book 1.7 ·
P / Cash Flow -5.6 ·
P / FCF -5.6 ·
Earnings Yield -105.7% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-31
Net Income $-161M$-78M
Diluted EPS $-18.56$-105.38
Balance Sheet
2025-12-312024-12-31
Current Ratio 20.0
Quick Ratio 18.8
Cash Flow
2025-12-312024-12-31
Free Cash Flow $-139M

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.